BioNTech SE (LON:0A3M)
93.72
+0.63 (0.68%)
At close: May 12, 2026
BioNTech SE Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 9,939 | 7,675 | 9,762 | 11,664 | 13,875 | 1,693 |
Short-Term Investments | 4,700 | 7,202 | 7,022 | 4,885 | 189.4 | 381.6 |
Cash & Short-Term Investments | 14,639 | 14,877 | 16,784 | 16,549 | 14,065 | 2,074 |
Cash Growth | 3.75% | -11.36% | 1.42% | 17.66% | 578.04% | 53.95% |
Accounts Receivable | 539.2 | 924.2 | 1,464 | 2,156 | 7,146 | 12,382 |
Other Receivables | 8.9 | 8.1 | 10 | 4.9 | - | - |
Total Trade Receivables | 548.1 | 932.3 | 1,474 | 2,161 | 7,146 | 12,382 |
Inventory | 103.8 | 110.7 | 283.3 | 357.7 | 439.6 | 502.5 |
Other Current Assets | 240.7 | 226.4 | 262.7 | 460 | 272.3 | 113.8 |
Total Current Assets | 15,532 | 16,147 | 18,804 | 19,527 | 21,922 | 15,072 |
Net Property, Plant & Equipment | 1,318 | 1,291 | 1,183 | 971.6 | 821.1 | 520.4 |
Other Intangible Assets | 1,547 | 1,606 | 790.4 | 804.1 | 158.5 | 202.4 |
Goodwill | 370.5 | 367.9 | 380.6 | 362.5 | 61.2 | - |
Long-Term Investments | 2,280 | 2,554 | 1,254 | 1,176 | 80.2 | 21.3 |
Other Long-Term Assets | 26.9 | 22.8 | 117.8 | 164.7 | 236.1 | 14.4 |
Total Assets | 21,074 | 21,989 | 22,530 | 23,006 | 23,279 | 15,831 |
Accounts Payable | 468.8 | 534.9 | 426.7 | 354 | 204.1 | 160 |
Accrued Expenses | 167 | 145.3 | 144.8 | 269.3 | 367.2 | 110.2 |
Current Portion of Leases | 56.7 | 52.2 | 39.5 | 28.1 | 36 | 129.9 |
Unearned Revenue | 758.5 | 754.9 | 294.9 | 353.3 | 101.5 | 276.1 |
Other Current Liabilities | 314 | 655 | 1,617 | 1,066 | 2,242 | 2,805 |
Total Current Liabilities | 1,765 | 2,142 | 2,523 | 2,071 | 2,951 | 3,482 |
Long-Term Leases | 246.1 | 215.2 | 214.7 | 191 | 176.2 | 171.6 |
Other Long-Term Liabilities | 365.2 | 406.9 | 380.7 | 498.9 | 96.7 | 283.9 |
Total Long-Term Liabilities | 611.3 | 622.1 | 595.4 | 689.9 | 272.9 | 455.5 |
Total Liabilities | 2,376 | 2,764 | 3,119 | 2,760 | 3,224 | 3,937 |
Common Stock | 259 | 259 | 248.6 | 248.6 | 248.6 | 246.3 |
Treasury Stock | -6.1 | -7.7 | -8.6 | -10.8 | -5.3 | -3.8 |
Additional Paid-in Capital | 2,468 | 2,473 | 1,399 | 1,229 | 1,828 | 1,674 |
Accumulated Other Comprehensive Income | -1,453 | -1,462 | -1,326 | -984.6 | -848.9 | 93.9 |
Retained Earnings | 17,430 | 17,962 | 19,098 | 19,763 | 18,833 | 9,883 |
Shareholders' Equity | 18,698 | 19,224 | 19,411 | 20,246 | 20,056 | 11,894 |
Total Liabilities & Equity | 21,074 | 21,989 | 22,530 | 23,006 | 23,279 | 15,831 |
Total Debt | 302.8 | 267.4 | 254.2 | 219.1 | 212.2 | 301.5 |
Net Cash (Debt) | 14,336 | 14,610 | 16,529 | 16,330 | 13,852 | 1,773 |
Net Cash Growth | -1.87% | -11.61% | 1.22% | 17.89% | 681.38% | 60.10% |
Net Cash Per Share | 58.63 | 60.45 | 68.76 | 67.28 | 55.45 | 6.83 |
Book Value | 18,698 | 19,224 | 19,411 | 20,246 | 20,056 | 11,894 |
Book Value Per Share | 76.47 | 79.54 | 80.75 | 83.42 | 80.29 | 45.80 |
Tangible Book Value | 16,781 | 17,250 | 18,240 | 19,079 | 19,836 | 11,691 |
Tangible Book Value Per Share | 68.63 | 71.37 | 75.87 | 78.61 | 79.41 | 45.02 |
Updated Mar 31, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.